Dan Su

4.7k citations

139 papers · 2.7k indexed · h-index 32

Impact in

Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer Genomics and Diagnostics
Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research

Papers in ⓘ

Oncology 63
- Pancreatic and Hepatic Oncology Research 15
- Cancer Immunotherapy and Biomarkers 12
- Cancer Cells and Metastasis 11
- Lung Cancer Research Studies 9
Molecular Biology 48

Co-authors: Lisha Ying (23 shared papers)Weimin Mao (10 shared papers)Liming Sheng (5 shared papers)Jianguo Feng (4 shared papers)Herbert Yu (8 shared papers)Fanrong Zhang (9 shared papers)Junzhou Wu (7 shared papers)Hao Jiang (3 shared papers)
Journals: Oncotarget (5 papers)Cancer Letters (4 papers)Journal of Clinical Oncology (4 papers)Heliyon (3 papers)International Journal of Cancer (2 papers)
Partner nations: China United States Italy

In The Last Decade

Dan Su

129 papers receiving 2.7k citations

Peers

Countries citing papers authored by Dan Su

Since Specialization

Citations

This map shows the geographic impact of Dan Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Su more than expected).

Fields of papers citing papers by Dan Su

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Su. The network helps show where Dan Su may publish in the future.

Co-authors

The 25 scholars most cited alongside Dan Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Dan Su Line = papers co-authored together Dan Su links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 139 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Exosome-derived miR-339-5p mediates radiosensitivity by targeting Cdc25A in locally advanced esophageal squamous cell carcinoma Oncogene ·Aiping Luo, Xuantong Zhou, Xing Shi, Yahui Zhao, Yu Men, Xiao Chang, Hongyan Chen, Fang Ding, Yi Li, Dan Su, Zefen Xiao, Zhouguang Hui, Zhihua Liu	2019	108
2	Circular RNA circBFAR promotes the progression of pancreatic ductal adenocarcinoma via the miR-34b-5p/MET/Akt axis Molecular Cancer ·Xiaofeng Guo, Quanbo Zhou, Dan Su, Yuming Luo, Zhiqiang Fu, Leyi Huang, Zhiguo Li, Decan Jiang, Yao Kong, Zhihua Li, Rufu Chen, Changhao Chen	2020	99
3	Genetic polymorphisms and treatment response in advanced non-small cell lung cancer Lung Cancer ·Dan Su, Shenglin Ma, Peng Liu, Zhiming Jiang, Wangxia Lv, Yimin Zhang, Qinghua Deng, Stephanie M. Smith, Herbert Yu	2007	96
4	Serum fibrinogen is an independent prognostic factor in operable nonsmall cell lung cancer International Journal of Cancer ·Liming Sheng, Min Luo, Xiaojiang Sun, Nengming Lin, Weimin Mao, Dan Su	2013	94
5	Prognostic significance of programmed death-1 and programmed death-ligand 1 expression in patients with esophageal squamous cell carcinoma Oncotarget ·Kaiyan Chen, Guoping Cheng, Fanrong Zhang, Nan Zhang, Dan Li, Jiaoyue Jin, Junzhou Wu, Lisha Ying, Weimin Mao, Dan Su	2016	92
6	Different effects of LDH-A inhibition by oxamate in non-small cell lung cancer cells Oncotarget ·Yang Yang, Dan Su, Lin Zhao, Dan Zhang, Jiaying Xu, Jianmei Wan, Saijun Fan, Ming Chen	2014	92
7	Paris saponin I induces apoptosis via increasing the Bax/Bcl-2 ratio and caspase-3 expression in gefitinib-resistant non-small cell lung cancer in vitro and in vivo Molecular Medicine Reports ·Hao Jiang, Pengjun Zhao, Dan Su, Jianguo Feng, Shenglin Ma	2014	86
8	ERCC1 Genotype and Phenotype in Epithelial Ovarian Cancer Identify Patients Likely to Benefit From Paclitaxel Treatment in Addition to Platinum-Based Therapy Journal of Clinical Oncology ·Stephanie M. Smith, Dan Su, Irene A. Rigault de la Longrais, Peter E. Schwartz, Manuela Puopolo, Thomas Rutherford, Gil Mor, Herbert Yu, Dionyssios Katsaros	2007	84
9	MDM2 promotes epithelial–mesenchymal transition and metastasis of ovarian cancer SKOV3 cells British Journal of Cancer ·Ying Chen, Dandan Wang, Yeping Wu, Dan Su, Tianyi Zhou, Renhua Gai, Yingying Fu, Lin Zheng, Qiaojun He, Hong Zhu, Bo Yang	2017	69
10	High performance of targeted next generation sequencing on variance detection in clinical tumor specimens in comparison with current conventional methods Journal of Experimental & Clinical Cancer Research ·Dan Su, Dadong Zhang, Kaiyan Chen, Jing Lü, Junzhou Wu, Xinkai Cao, Lisha Ying, Qihuang Jin, Yizhou Ye, Zhenghua Xie, Lei Xiong, Weimin Mao, Fugen Li	2017	66
11	Stathmin and tubulin expression and survival of ovarian cancer patients receiving platinum treatment with and without paclitaxel Cancer ·Dan Su, Stephanie M. Smith, Mario Preti, Peter E. Schwartz, Thomas Rutherford, Guido Menato, Saverio Danese, Shenglin Ma, Herbert Yu, Dionyssios Katsaros	2009	63
12	S-allylcysteine, a garlic derivative, suppresses proliferation and induces apoptosis in human ovarian cancer cells in vitro Acta Pharmacologica Sinica ·Yasi Xu, Jianguo Feng, Dan Zhang, Bo Zhang, Min Luo, Dan Su, Nengming Lin	2013	60
13	Tumor-neuroglia interaction promotes pancreatic cancer metastasis Theranostics ·Dan Su, Xiaofeng Guo, Leyi Huang, Huilin Ye, Zhiguo Li, Longfa Lin, Rufu Chen, Quanbo Zhou	2020	58
14	ABO blood group and nasopharyngeal carcinoma risk in a population of Southeast China International Journal of Cancer ·Liming Sheng, Xiaojiang Sun, Lizhen Zhang, Dan Su	2013	58
15	A Nomogram to Predict Brain Metastases of Resected Non-Small Cell Lung Cancer Patients Annals of Surgical Oncology ·Fanrong Zhang, Weihui Zheng, Lisha Ying, Junzhou Wu, Shaoyuan Wu, Shenglin Ma, Dan Su	2016	56
16	OTUD1 Activates Caspase‐Independent and Caspase‐Dependent Apoptosis by Promoting AIF Nuclear Translocation and MCL1 Degradation Advanced Science ·Qingyu Luo, Xiaowei Wu, Pengfei Zhao, Yabing Nan, Wan Chang, Xiaolin Zhu, Dan Su, Zhihua Liu	2021	55
17	circCUL2 induces an inflammatory CAF phenotype in pancreatic ductal adenocarcinoma via the activation of the MyD88-dependent NF-κB signaling pathway Journal of Experimental & Clinical Cancer Research ·Shangyou Zheng, Chonghui Hu, Hongcao Lin, Guolin Li, Renpeng Xia, Xiang Zhang, Dan Su, Zhihua Li, Quanbo Zhou, Rufu Chen	2022	48
18	Elevated platelet count is a strong predictor of poor prognosis in stage I non-small cell lung cancer patients Platelets ·Yongling Ji, Liming Sheng, Xianghui Du, Guoqin Qiu, Dan Su	2014	44
19	SOX9/FXYD3/Src Axis Is Critical for ER+ Breast Cancer Stem Cell Function Molecular Cancer Research ·Yue Xue, Lihua Lai, Wenwen Lian, Xintao Tu, Jiaojiao Zhou, Ping Dong, Dan Su, Xiaojia Wang, Xuetao Cao, Yiding Chen, Qingqing Wang	2018	43
20	Inhibition of cell proliferation by mild hyperthermia at 43°C with Paris Saponin I in the lung adenocarcinoma cell line PC-9 Molecular Medicine Reports ·Pengjun Zhao, Hao Jiang, Dan Su, Jianguo Feng, Shenglin Ma, Xinhai Zhu	2014	43

About Dan Su

Dan Su is a scholar working on Oncology, Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine and Surgery, having authored 139 papers that have together received 2.7k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (17 papers), Pancreatic and Hepatic Oncology Research (15 papers), Lung Cancer Treatments and Mutations (13 papers), Cancer Immunotherapy and Biomarkers (12 papers), Esophageal Cancer Research and Treatment (11 papers), Cancer Cells and Metastasis (11 papers), Lung Cancer Research Studies (9 papers) and Venous Thromboembolism Diagnosis and Management (7 papers). The work is most often cited by research in Cancer Research (795 citations), Oncology (993 citations), Molecular Biology (1.4k citations), Pulmonary and Respiratory Medicine (571 citations) and Internal Medicine (63 citations). Dan Su has collaborated with scholars based in China, United States and Italy. Frequent co-authors include Lisha Ying, Weimin Mao, Liming Sheng, Jianguo Feng, Herbert Yu, Fanrong Zhang, Junzhou Wu, Hao Jiang, Pengjun Zhao and Kaiyan Chen. Their work appears in journals such as Oncotarget, Cancer Letters, Journal of Clinical Oncology, Heliyon and International Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact